Deep intronic founder mutations identified in the <i>ERCC4</i> / <i>XPF</i> gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosumChikako Senju, Tomoo Ogi|Proceedings of the National Academy of Sciences|2023Cited by 12